Toggle navigation
Leadership in clinical care
HOME
CE
TOPICS
Case Reports
Coding
Contact Lenses & Solutions
Cornea
Diagnostics
Dry Eye
Eyelids
Glaucoma
Low Vision
Neuro-ophthalmic Disorders
News
Ophthalmic Lenses & Dispensary
Optometric Study Center
Pharmaceuticals
Practice Management
Products
Retina
Surgery
Systemic Disease
Technology
Multimedia
Web Exclusives
EVENTS
CE Programs
Educational Programs (Non-CE)
JOBS
July 15, 2014
Read Digital Edition
Archive
Subscriptions
Features
Annual Glaucoma Report
Tailor Your Approach to PXG Management
Patients with pseudoexfoliative glaucoma often require a more thorough diagnostic work-up and earlier intervention than those with POAG. So how do these conditions differ, and why?
The Changing and Challenging Epidemiology of Glaucoma
As the aging population doubles and minority groups skyrocket, we face increased challenges in tailoring our glaucoma care to each patient.
Plotting the Path of Progression
Our success in managing glaucoma hinges on our ability to recognize—and make sense of—both structural and functional changes.
Clinical Care
Scleritis: When a Red Eye Raises a Red Flag
This painful inflammation is often an indicator of more serious health concerns.
Departments
Chairside
iPhone Refraction? iLove It!
An app that refracts is like having an OD in your pocket—which begs the question: Is that an OD in your pocket or are you just happy to see me?
Clinical Quandaries
Steroid Adds to the Pressure
This uveitis patient is also a steroid responder. Which problem do you tackle first?
Coding Connection
No More ‘Glaucoma Checks’
Avoid vague, stock phrases in your medical record. Get down to specifics.
Cornea and Contact Lens Q & A
Fresh Ink
Corneal tattooing can mask scars and leucoma while improving visual acuity. But how is this technique performed?
Diagnostic Quiz
A 50-50 Split
How would you treat this patient?
News Review
Is Glaucoma a Brain Disease?
New research shows that the brain—not the eye—controls the cellular process that leads to glaucoma.
Omega-3s Suppress CNV
For the first time, omega-3 fatty acids were shown to inhibit choroidal angiogenesis.
Enough ODs, Workforce Study Says
There will be enough ODs—and perhaps an oversupply—into the year 2025.
Eye Disease Costs to Skyrocket by 2050
Costs related to eye disease are expected to skyrocket 376% by 2050.
In the News
The latest industry news.
Outlook
Rise and Shine
ODs are in prime position to address the growing needs of under-served glaucoma patients, elevating the profession with distinction.
Product Review
Product Review
The latest in industry products.
Retina Quiz
Pale in Comparison
This patient presented with a lifelong history of poor visual acuity in both eyes and abnormally light skin pigmentation.
Review of Systems
The Tangled Web We Weave
Arteriovenous malformations can have widespread effects on the body, including the eye.
Surgical Minute
ASP: Take a Bite Out of RCE
Even Cleopatra would favor this simple, needle-based procedure.
Therapeutic Review
A Hole-in-One?
Is there a role for iridotomy when managing patients with pigmentary glaucoma?
×
Full Image